eujobs.coEU jobs in brussels
Post a JobHeadhunter

FIPRA International SRL

Acronym: FIPRA

General Information

Identification Code: 58746194306-23
Website: [object Object]
Entity Form: Limited Company
Registration Category: Professional consultancies
Registration Date: 10/6/2010
Last Update: 5/14/2024
EP Accredited Number: 41

Mission & Interests

Goals: Founded in 2000, FIPRA International is a leading European and international public affairs consultancy advising clients on a range of government relations and regulatory policy issues. FIPRA International has relationships with a range of other consultancies across Europe and globally: the wider FIPRA network extends to over 50 countries both in Europe and internationally. FIPRA’s business focus is on the provision of advice and assistance in “public affairs” also termed “government relations”. We advise companies and non-corporate clients on how best to engage with government and public institutions on questions of policy, legislation and regulation that concern them.
Interests Represented: Advances interests of their clients
Interests:
  • Borders and security
  • Budget
  • Business and industry
  • Climate action
  • Competition
  • Consumers
  • Culture
  • Culture and media
  • Customs
  • Digital economy and society
  • Economy, finance and the euro
  • Education and training
  • Employment and social affairs
  • Energy
  • Enlargement
  • Environment
  • External relations
  • Food safety
  • Foreign affairs and security policy
  • Institutional affairs
  • International co-operation and development
  • Justice and fundamental rights
  • Maritime affairs and fisheries
  • Public health
  • Regional policy
  • Research and innovation
  • Single market
  • Sport
  • Taxation
  • Trade
  • Trans-European Networks
  • Transport
Levels of Interest:
  • national
  • global
  • european
  • sub-national

Activities

Main EU Legislative Proposals: FIPRA’s business focus is on the provision of advice and assistance in “public affairs” also termed “government relations”. We advise companies and non-corporate clients on how best to engage with government and public institutions on questions of policy, legislation and regulation that concern them. In Europe, much of our work is undertaken with the institutions of the European Union. Our entry on the joint European Commission and European Parliament Register relates to our work undertaken on behalf of clients in connection with the EU institutions. Specific EU legislative proposals and/or policies being followed vary according to the interests of our clients, but in the course of 2022 these have included: EU environmental policy, including the European Green Deal and Roadmap; public consultations by DG COMP on aspects of EU competition policy (mergers, anti-trust, state aid); public consultations by DG GROW, DG CNECT and DG MOVE on aspects of EU mobility and connected intelligent transport systems (C-ITS) and related data aspects; EU policies on health, wellbeing and pharmaceutical policy, including the EU Roadmap on pharmaceutical strategy; EU chemicals legislation REACH, authorisation of substances; EU trade policy, in particular EU-US (TTIP) and EU-UK negotiations for a post-Brexit EU-UK trade agreement; EU data and technology policy, including on access to data and data-sharing, and the proposed White Paper on artificial intelligence policy. FIPRA is also registered on the EU Health Policy Platform (see: https://ec.europa.eu/health/interest_groups/policy_platform_en) representing HIV Outcomes: https://hivoutcomes.eu
Communication Activities: FIPRA acts as the secretariat to ACHIEVE, a multi-stakeholder coalition bringing together the hepatitis community in Europe, including patients, NGOs working with at-risk groups, clinicians and public health experts. ACHIEVE’s goal is to secure political will and adequate policy measures to support the elimination of viral hepatitis B and C in Europe by 2030.To achieve this goal, the coalition engages with policy makers at EU level to make viral hepatitis elimination a political priority and to ensure Member States receive adequate support and guidance. ACHIEVE is enabled by sponsorship of Abbot, AbbVie, Cepheid and Gilead Sciences: http://achievehepatitiselimination.eu FIPRA acted as the secretariat of All Policies for a Healthy Europe, a multi-stakeholder initiative composed of non-governmental and not-for-profit organisations, thinktanks, trade associations and individual companies. All Policies for a Healthy Europe aims to ensure that health and well-being are considered in all relevant EU policy areas, championing a broad vision of health policy, encompassing Europe’s role in addressing the multi-dimensional determinants of health and well-being – economic, social, environmental and political. This initiative is enabled by sponsorship from Johnson & Johnson and Microsoft. See: http://www.healthyeurope.eu FIPRA acts as the secretariat of HIV Outcomes, a multi-stakeholder initiative that brings together patient organisations, medical professionals, academics, public institutions and the private sector to align on a new policy and clinical agenda to address the crucial unmet needs of people living with HIV across Europe. HIV Outcomes engages with policy makers at the European and national level to advocate for the implementation of policy changes to improve the long-term health outcomes and quality of life of people living with HIV. The initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare. See: https://hivoutcomes.eu FIPRA acts as the secretariat to the RWE4Decisions initiative, facilitating multi-stakeholder discussions between Health Technology Assessment (HTA) bodies, payers, clinicians, patient representatives, researchers, industry and academics. The RWE4Decisions stakeholder group authored a paper, identifying how Real-World Evidence (RWE) can support HTA/payer decisions about highly innovative technologies. In 2021, the RWE4Decisions initiative was enabled by the sponsorship of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Astra Zeneca, Gilead Sciences, Amgen and Roche. See: https://rwe4decisions.com/
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 227 Rue de la Loi
Post Code: 1040
City: Brussels
Country: BELGIUM
Phone: [object Object]

EU Office

Address: 227 Rue de la Loi
Post Code: 1040
City: Brussels
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]

Membership Information

Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 3
Members75 Percent: 3
Members: 74
Members F T E: 71
Info Members: Robert Madelin is a consultant to FIPRA. He is married to Marie-Christine Jalabert who works at the Directorate-General for Energy (DG ENER).

Structure

Structure Type: Structure
Organisation Members: BritCham - British Chamber of Commerce in Belgium Spanish Chamber of Commerce Competition Law Forum (CLF) European Policy Centre (EPC) European Public Affairs Consultancies Association (EPACA) European Risk Forum (ERF) 1 1 FIPRA International is a member of the ERF, a not-for-profit think tank with a focus on regulatory risk, better regulation, impact assessment, the best use of science and related matters. FIPRA offers pro-bono support to the ERF.